NextOmics Biosciences is a biotechnology company founded in 2011 in Wuhan, China. As one of the first providers of third-generation sequencing services in China based on PacBio SMRT Sequencing, NextOmics completed hundreds of projects ranging from for de novo genome assembly to full-length transcriptome analysis. NextOmics is one of the early commercial sequencing service providers in China to purchase a PacBio Sequel System in 2016, and announced the purchase of five additional Sequel sequencers early 2017. Currently, Nextomics operates multiple PacBio Sequel sequencers, along with BioNano Irys , and is rapidly becoming a world leader in sequencing services using PacBio long-read sequencing technology.
Address: Building C6, Biolake, No. 666, Gaoxin Road, Wuhan，China